Oncology Sponsored The Compound Effect: Real-World Evidence for the Impact of C... In a new report, Medscape Medical Affairs explores the question of whether a coordinated programme drives more real-world behaviour change.
Sales & Marketing Sponsored Are Insights leaders seeing real commercial value from AI ad... Day One Strategy’s second annual AI in Pharma State of Play report addresses the challenges Pharma Insights teams are facing as AI adoption continues.
Sales & Marketing Sponsored Solution Spotlight: Within3 Within3’s disease community analytics provide an understanding of influence within a disease community – not just expertise.
Sales & Marketing Coming soon: The Life Sciences Industry Report 2025 – insigh... Prepare for 2025 with pharmaphorum’s Life Sciences Report, featuring expert insights on AI in drug development, gene therapy, and top industry trends
News MSD stops trials of BTK inhibitor for blood cancers MSD has stopped development of BTK inhibitor nemtabrutinib, acquired via its $2.7bn takeover of ArQule, after trial results pointed to a safety issue.
Sales & Marketing Sponsored Securing your ROI: Turning post-acquisition integration into... Join Forinnovia and Little Cube Consulting for a webinar on securing post-acquisition ROI.